TORONTO, March 6, 2013 (GLOBE NEWSWIRE) -- CardioComm Solutions, Inc. (TSX-V:EKG) ("CardioComm Solutions" or the "Company"), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, today announced a distribution agreement with firstSTREET for Boomers and Beyond Inc., based out of Virginia ("Vendor"), a specialist in the design and marketing of innovative specialty products for seniors. firstSTREET will be selling the HeartCheck PEN into the U.S. market commencing immediately.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=17473
The agreement designates firstSTREET as an authorized re-seller of the HeartCheck PEN. CardioComm Solutions anticipates revenue from sales of devices as well as generation of revenue from ECG triage and interpretation services through use of the Company's SMART Monitoring ECG service.
As a direct marketing company, firstSTREET advertisements will reach the senior customer through the Internet, monthly catalogs and national periodical-based publications. Their website lists such publications as AARP's Bulletin and Magazine, Parade and USA Weekend. Their internet site has been recognized as one of the Top 500 Internet Web sites by Internet Retailer magazine, placing them in the company of: Amazon, BestBuy, Dell, eBay, LandsEnd, and DrugStore.com. Further they are the only Top 500 internet site that focuses exclusively on the senior demographic, which represents the fastest growing on-line user group.
"The launch of our second American distribution agreement follows discussions initiated in November 2012," said Etienne Grima, Chief Executive Officer for CardioComm Solutions. "This one distribution agreement is a significant opportunity for CardioComm Solutions to introduce the HeartCheck PEN specifically into the seniors market in the United States. Given the network of channel partners and firstSTREET's own household file of 2.5 million customers with an average of 65 years of age, this launch meets our objective to access elderly consumers interested in the preservation of their health as well as those at risk for developing arrhythmia based cardiac disease due to underlying conditions such as hypertension, diabetes, older age, familial histories and taking high risk medications."
Consumers purchasing the HeartCheck PEN ECG will have access to CardioComm Solutions' SMART Monitoring ECG service, a first free ECG interpretation by the CardioComm Solutions ECG service and the free GEMS Home software. After the free interpretation, the HeartCheck PEN can be enabled to display the ECG waveform at no additional cost (see accompanying image).
"firstSTREET has placed the HeartCheck PEN on the front cover of their spring catalogue as a feature product anticipated to be sent to 350,000 of their opt in clients as of March 4, 2013, as well as placing it on the new arrivals featured products section of their website at www.firststreetonline.com," added Mr. Simi Grosman, member of the Company's Board of Directors. "With completion of two American distributor agreements, CardioComm Solutions will continue to work in closing additional distribution and partnership agreements for our family of HeartCheck and Global ECG Management (GEMSTM) solutions, each with a different focus within multiple global geographic and demographic markets."
About CardioComm Solutions
CardioComm Solution's patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions, Inc. is headquartered in Toronto, Canada, with offices in Victoria, B.C.
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.